Sharechat Logo

Argosy enters unconditional sale of Auckland property for $31 million

Monday 26th March 2018

Text too small?

Argosy Property has entered into an unconditional sale of property in Auckland for $31 million, a price that presents a 13 percent premium over its latest book value, the company said in a release to the stock exchange.

According to Argosy, the Feb 28 book value of 7 and 7A Wagener Place, St Lukes, was $27.4 million. The settlement is expected to occur in July 2018.

“The market for commercial real estate remains attractive for long-term investors divesting real estate," said chief executive Peter Mence. "The sale presents an opportunity to reduce our retail exposure in an area where there will be increasing competition. It allows us to keep delivering on our strategy and we will reinvest the proceeds into other brownfield development opportunities across the portfolio."

Argosy has been diversifying its property portfolio outside Auckland, buying industrial sites which now make up 40 percent of its portfolio, according to the November half-year report. 

Separately, it said it settled the sale of 14 Tunnel Grove, Wellington for $2.8 million. 

The stock last traded at $1.00 and has shed 7.8 percent so far this year. 

(BusinessDesk)



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors